Translational Control by 4E-BP1/2 Suppressor Proteins Regulates Mitochondrial Biosynthesis and Function during CD8+ T Cell Proliferation

J Immunol. 2022 Jun 15;208(12):2702-2712. doi: 10.4049/jimmunol.2101090. Epub 2022 Jun 6.

Abstract

CD8+ T cell proliferation and differentiation into effector and memory states are high-energy processes associated with changes in cellular metabolism. CD28-mediated costimulation of T cells activates the PI3K/AKT/mammalian target of rapamycin signaling pathway and induces eukaryotic translation initiation factor 4E-dependent translation through the derepression by 4E-BP1 and 4E-BP2. In this study, we demonstrate that 4E-BP1/2 proteins are required for optimum proliferation of mouse CD8+ T cells and the development of an antiviral effector function. We show that translation of genes encoding mitochondrial biogenesis is impaired in T cells derived from 4E-BP1/2-deficient mice. Our findings demonstrate an unanticipated role for 4E-BPs in regulating a metabolic program that is required for cell growth and biosynthesis during the early stages of CD8+ T cell expansion.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CD8-Positive T-Lymphocytes / metabolism
  • Cell Cycle Proteins / metabolism
  • Cell Proliferation
  • Eukaryotic Initiation Factors* / genetics
  • Eukaryotic Initiation Factors* / metabolism
  • Mammals / genetics
  • Mice
  • Organelle Biogenesis
  • Phosphatidylinositol 3-Kinases / metabolism
  • Phosphoproteins* / metabolism
  • Phosphorylation
  • Protein Biosynthesis

Substances

  • Cell Cycle Proteins
  • Eukaryotic Initiation Factors
  • Phosphoproteins

Grants and funding